ArticleThe Journal of infection2013
A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC.
Article in The Journal of infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- 1-Phenyl-RSC advances · 2020Article
- A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity.Vaccines · 2020Article
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.Frontiers in microbiology · 2020Review
- Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2).Frontiers in cellular and infection microbiology · 2020Review
- Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV.Antibodies (Basel, Switzerland) · 2019Article
- A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.Emerging microbes & infections · 2017Article
- Middle East Respiratory Syndrome Virus Pathogenesis.Seminars in respiratory and critical care medicine · 2016Review
- The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses.Scientific reports · 2015Article
- Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control.Experimental & molecular medicine · 2015Review
- Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27.Scientific reports · 2015Article
- Receptor-binding domain-based subunit vaccines against MERS-CoV.Virus research · 2015Review
- Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.Clinical microbiology reviews · 2015Review
- Receptor binding domain based HIV vaccines.BioMed research international · 2015Review
- The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.Journal of the Formosan Medical Association = Taiwan yi zhi · 2014Review
- Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV.Bioinformation · 2014Article
- Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs.Journal of virology · 2014Article
- Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus.The Journal of infection · 2013Article
- Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC.The Journal of infection · 2013Article
- Interspecies transmission and emergence of novel viruses: lessons from bats and birds.Trends in microbiology · 2013Review
- Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.Journal of virology · 2013Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.